Screening for Primary Aldosteronism in Treatment-Resistant Hypertension
Faculty and trainees within the Department of Medicine who are involved in the care of patients need to receive regular updates on recent advances and guidelines in the field of internal medicine. Clinical scenarios will be used to review the current management of common medical conditions, including chronic pain and opioid abuse. Multidisciplinary sessions will be also used to educate learners about human trafficking and the role of physicians in identifying and assisting victims in the community. The overall aim of the series is to advance clinical knowledge, enhance the quality of patient care, and improve treatment outcomes.
Physicians, medical students, fellows, and residents.
At the conclusion of the session, the participants should be able to:
Describe the prevalence of primary aldosteronism and articulate the screening gap in patients with resistant hypertension.
Discuss the importance of identifying primary aldosteronism in patients with hypertension.
Review the pathophysiology of aldosteronism, which patients should be considered for screening, and an algorithm for how patients should be screened.
Describe the next steps for confirmatory testing if needed for patients with positive aldosteronism screening results.
Diagram an evidence-based algorithm for subtype classification.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation